If you have been reading about REV-ERB agonist and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-02-07. Where a claim depends on a specific study, the study is described rather than over-claimed.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small-molecule ligand; not a hormone or peptide |
| Molecular formula | C20H24ClN3O4S | Reported for the free base |
| CAS Registry Number | 1379686-30-2 | Unique chemical identifier |
| Common synonyms | SR9009; stenabolic | Stenabolic is informal and not an official name |
| Reported targets | REV-ERBα and REV-ERBβ | Nuclear receptors linked to circadian and metabolic regulation |
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
=== World War I === In World War I, the US Navy contracted for 18 refrigerated ships for hauling provisions to the troops in Europe. They were launched 1918 and 1919 as the war was ending and were nearly all scrapped by 1933 in the Great Depression as an economy move. Most were built in Baltimore Dry Dock in Baltimore, Maryland, Moore Dry Dock Company in Oakland, California, and Standard SB Co. in Shooters Island, New York.
Organized crime groups generate large amounts of money by activities such as drug trafficking, arms smuggling, extortion, theft, and financial crime. These illegally sourced assets are of little use to them unless they can disguise it and convert it into funds that are available for investment into legitimate enterprise. The methods they use for converting its 'dirty' money into 'clean' assets encourages corruption. Organized crime groups need to hide the money's illegal origin. This allows for the expansion of OC groups, as the 'laundry' or 'wash cycle' operates to cover the money trail and convert proceeds of crime into usable assets. Money laundering is bad for international and domestic trade, banking reputations and for effective governments and rule of law. This is due to the methods used to hide the proceeds of crime. These methods include, but are not limited to: buying easily transported values, transfer pricing, and using "underground banks," as well as infiltrating firms in the legal economy. Launderers will also co-mingle illegal money with revenue made from businesses in order to further mask their illicit funds. Accurate figures for the amounts of criminal proceeds laundered are almost impossible to calculate, rough estimates have been made, but only give a sense of the scale of the problem and not quite how great the problem truly is. The United Nations Office on Drugs and Crime conducted a study, they estimated that in 2009, money laundering equated to about 2.7% of global GDP; this is equal to about 1.6 trillion US dollars.
Mathematical logic Set theory Proof theory Model theory Recursion theory Modal logic Intuitionistic logic Philosophical logic Logical reasoning Modal logic Deontic logic Doxastic logic Logic in computer science Programming language semantics Formal methods (Formal verification) Type theory Logic programming Multi-valued logic Fuzzy logic
Other powerful extensions to the dead-end elimination algorithm include the pairs elimination criterion, and the generalized dead-end elimination criterion. This algorithm has also been extended to handle continuous rotamers with provable guarantees. Although the Dead-end elimination algorithm runs in polynomial time on each iteration, it cannot guarantee convergence. If, after a certain number of iterations, the dead-end elimination algorithm does not prune any more rotamers, then either rotamers have to be merged or another search algorithm must be used to search the remaining search space. In such cases, the dead-end elimination acts as a pre-filtering algorithm to reduce the search space, while other algorithms, such as A*, Monte Carlo, Linear Programming, or FASTER are used to search the remaining search space.
Sources: en.wikipedia.org
=== Senate Foreign Relations Committee === Biden was a longtime member of the Senate Foreign Relations Committee. He became its ranking minority member in 1997, and chaired it from June 2001 to 2003 and 2007 to 2009. His positions were generally liberal internationalist. He collaborated effectively with Republicans and sometimes went against elements of his own party. During this time he met with at least 150 leaders from 60 countries and international organizations, becoming a well-known Democratic voice on foreign policy. Biden voted against authorization for the Gulf War in 1991. He became interested in the Yugoslav Wars after hearing about Serbian abuses during the Croatian War of Independence in 1991. Once the Bosnian War broke out, Biden was among the first to call for the "lift and strike" policy. George H. W. Bush and Bill Clinton were both reluctant to implement the policy, fearing Balkan entanglement. In April 1993, Biden had a tense three-hour meeting with Serbian leader Slobodan Milošević. Biden worked on several versions of legislative language urging the U.S. toward greater involvement. He has called his role in affecting Balkan policy in the mid-1990s his "proudest moment in public life" related to foreign policy. In 1999, during the Kosovo War, Biden supported the NATO bombing of Yugoslavia. He and Senator John McCain co-sponsored the McCain-Biden Kosovo Resolution, which called on Clinton to use all necessary force, including ground troops, to confront Milošević over Yugoslav actions toward Kosovo Albanians.
=== United States === The rate of obesity among children and adolescents in the United States has nearly tripled between the early 1980s and 2000. It has, however, not changed significantly between 2000 and 2006, with the most recent statistics showing a level just over 17 percent. In 2008, the rate of overweight and obese children in the United States was 32%, and had stopped climbing. In 2011, a national cohort study of infants and toddlers found that nearly one-third of US children were overweight or obese at nine months and two years old. In a follow-up study, infant weight status (healthy and obese) was strongly associated with preschool weight status.
== Absorption bands == IR spectroscopy is often used to identify structures because functional groups give rise to characteristic bands both in terms of intensity and position (frequency). The positions of these bands are summarized in correlation tables as shown below.
== Examinations == CBSE conducts the final examinations for Class 10 and Class 12 every year in February and March. The results are announced by the end of May. The board earlier conducted the AIEEE Examination for admission to undergraduate courses in engineering and architecture in colleges across India, however, the AIEEE exam was merged with the IIT-Joint Entrance Exam (JEE) in 2013. The standard examination is now called JEE (Main) and is henceforth conducted by National Testing Agency. CBSE also conducted AIPMT (All India Pre-Medical Test) for admission to major medical colleges in India. In 2014, the conduct of the National Eligibility Test for the grant of a junior research fellowship and eligibility for an assistant professor in institutions of higher learning was outsourced to CBSE. Apart from these tests, CBSE also conducts the Central Teacher Eligibility Test and the Class X optional proficiency test. With the addition of NET in 2014, the CBSE became the largest exam-conducting body in the world. On 10 November 2017, the Union Cabinet, chaired by Prime Minister Narendra Modi, cleared a proposal to create a National Testing Agency (NTA) as the premier autonomous body for conducting entrance examinations in the country. Beginning in 2018, various exams previously conducted by the CBSE were transferred to the NTA, including National Eligibility cum Entrance Test (Undergraduate), Joint Entrance Examination – Main, National Eligibility Test, Central Universities Common Entrance Test and others.
Although IV and oral acetylcysteine are equally effective for this indication, oral administration is generally poorly tolerated due to the higher dosing required to overcome its low oral bioavailability, its foul taste and odor, and a higher incidence of adverse effects when taken orally, particularly nausea and vomiting. Prior pharmacokinetic studies of acetylcysteine did not consider acetylation as a reason for the low bioavailability of acetylcysteine. Oral acetylcysteine is identical in bioavailability to cysteine precursors. However, 3% to 6% of people given intravenous acetylcysteine show a severe, anaphylaxis-like allergic reaction, which may include extreme breathing difficulty (due to bronchospasm), a decrease in blood pressure, rash, angioedema, and sometimes also nausea and vomiting. Repeated doses of intravenous acetylcysteine will cause these allergic reactions to progressively worsen in these people. Several studies have found this anaphylaxis-like reaction to occur more often in people given intravenous acetylcysteine despite serum levels of paracetamol not high enough to be considered toxic.
Sources: en.wikipedia.org
=== Urinary incontinence === Serotonin plays a key role in mechanisms involved in micturition and continence. Many potent compounds with high selectivity for 5-HT2C receptors have been synthesized and are promising candidates for further development for the treatment of stress urinary incontinence (SUI).
=== Anti-jamming technologies === The British had been aware that the Germans would determine the purpose of the system and attempt to interfere with it, and had designed in a variety of features and methods in order to address some of these issues even as the first stations were being built. The most obvious of these was CH's ability to operate on different frequencies, which was added to allow the stations to avoid any sort of continuous-broadcast interference on their operating frequency. Additionally, the Interference Rejection Unit, or IFRU, allowed the output of the intermediate stages of the amplifiers to be clipped in an attempt to finely tune the receiver to the station's own signals and help reject broadband signals. More complex was a system built into the CH displays, implemented in order to remove spurious signals from unsynchronized jamming pulses. It consisted of two layers of phosphor in the CRT screen, a quick-reacting layer of zinc sulphide below, and a slower "afterglow" layer of zinc cadmium sulphide on top. During normal operation the bright blue signal from the zinc sulphide was visible, and its signal would activate the yellow zinc cadmium sulphide layer, causing an "averaged" signal to be displayed in yellow. To filter out jamming pulses, a yellow plastic sheet was placed in front of the display, rendering the blue display invisible and revealing the dimmer yellow averaged signal. This is the reason many radars from the War through to the 1960s have yellow displays.
"Took up the cooperative movement" at its annual convention in 1919. Moved into its new 4-story building in the West End at the corner of Leverett and Ashland Street and moved in on November 13, 1920. The building contained the group's offices, cooperative grocery, creamery, shoe and dry goods store, and printing plant. The "Co-operative Wholesale Society" consisting of the "Finnish, Lithuanian, and Italian Co-operative of New England" had its offices and warehouse in this building as well. Jewish Progressive Order - Headquartered in Philadelphia. Supported the Palestine Restoration Fund by a "shekel tax" of 25 cents per member. Jewish National Workers Alliance Order of Brith Abraham - Founded in New York in 1859. Originally restricted to Reform Jews. Female lodges, consisting of the female relatives of members of the order, could be formed with the sanction of the Grand Lodge and could elect one of the Past Presidents of the male lodges as their officers. In 1899 there were 11,000 regular members and 1,000 members of the female lodges. 8,000 regular members and three-fifths of the 160 lodges were located in New York City. In 1923 it had 198 lodges, 15,152 benefit members, and 195 social members. It had 8,000 members when it became defunct in 1927. Headquarters in 1923 located at 266-268 Grand Street New York City. The ceremony of the order was calculated to inculcate the values of harmony, wisdom, and justice. The order's emblem was an "interlaced triangle" with a representation of Abraham about to sacrifice Jacob.
Medication Medical approaches include enhancement of residual enzyme activity (in cases where the enzyme is made but is not functioning properly), inhibition of other enzymes in the biochemical pathway to prevent buildup of a toxic compound, or diversion of a toxic compound to another form that can be excreted. Examples include the use of high doses of pyridoxine (vitamin B6) in some patients with homocystinuria to boost the activity of the residual cystathione synthase enzyme, administration of biotin to restore activity of several enzymes affected by deficiency of biotinidase, treatment with NTBC in Tyrosinemia to inhibit the production of succinylacetone which causes liver toxicity, and the use of sodium benzoate to decrease ammonia build-up in urea cycle disorders.
Sources: en.wikipedia.org
SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.
No. It has no approved medical indication, and human safety and efficacy data are limited. It appears in research chemical markets and is banned by some sports authorities.
Natural ligands include heme and certain metabolites; SR9009 is a synthetic small molecule with higher potency and selectivity in some assays. Its effects depend on cell type and timing. It is not a naturally occurring compound.
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.